News

Dr Lise Hunault, a researcher in the Centenary Institute’s Centre for Biomedical AI, has been awarded a major research grant from Breakthrough T1D, the leading global type 1 diabetes research and advocacy organisation, to advance islet-cell replacement therapies for type 1 diabetes.

A new biotechnology company, Vaxosome, has been launched to develop next-generation vaccines aimed at tackling some of the world’s most challenging infectious diseases.

The Snow Medical Research Foundation has today announced major long-term funding of $15.5 million for a new national research program targeting fatty liver disease, a condition that affects up to one in three Australians. The Centenary Institute will play a key role in the collaborative effort.

Centenary researchers have been awarded funding to commercialise a first‑of‑its‑kind medical AI platform designed to improve treatment decisions and reduce unnecessary surgeries for Australian cancer patients. The project, funded through the Australian Government’s Australia’s Economic Accelerator (AEA) Ignite program and led by Dr Yagiz Aksoy, Senior Clinical Research Fellow at Centenary’s Centre for Biomedical AI, ...

The Centenary Institute and the University of Sydney have launched a major new initiative that brings next-generation spatial biology technologies together to transform how health threats such as cancer, cardiovascular diseases and infectious diseases are studied and understood.

A major new research project funded by the Australian Research Council (ARC) Discovery Projects scheme is commencing, with the Centenary Institute playing a central role. The project will establish an advanced platform to improve therapeutic protein design, supporting future developments in drugs, diagnostics and biotechnology.

Centenary Institute researchers played a prominent role at the Australian Biology of Ageing Conference 2025 this week, contributing new scientific insights on how Australians can live healthier lives as they age.

Associate Professor Patrick Bertolino, Head of the Centre for Infection & Immunity at the Centenary Institute, and Associate Professor David Bowen from the same centre, have been awarded a 2025 Gastroenterological Society of Australia (GESA) Project Grant. The $50,000 grant will support their study ‘Decoding Microbiome–Liver Communication via Portal Tracts.’

The Centenary Institute has contributed to a major international study that has mapped how the human body responds to respiratory infections at a molecular level.

Congratulations to Professor Devanshi Seth, who has won the Healthcare Impact category in the STEM Sisters 2025 Women of Colour in STEM Awards.

A recent discovery from the Centenary Institute has been recognised as the 200th scientific breakthrough funded by cancer charity Tour de Cure since it began supporting research in 2007.

Two researchers from the Centenary Institute have secured competitive Pipeline Accelerator Grants from Therapeutic Innovation Australia (TIA), supporting the development of promising medical innovations.